About TDSPHARM
TDSPHARM is a company based in Eumseong (South Korea) founded in 2002. The company has 96 employees as of December 31, 2024. TDSPHARM offers products and services including General Medicines, Specialized Medicines, and Medical Supplies. TDSPHARM operates in a competitive market with competitors including Merck, AbbVie, Lilly, Roche and Novo Nordisk, among others.
- Headquarter Eumseong, South Korea
- Employees 96 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
- Legal Name Tdspharm Co., Ltd.
-
Annual Revenue
$18.66 M (USD)-8.42as on Dec 31, 2024
-
Net Profit
$2.52 M (USD)-20.69as on Dec 31, 2024
-
EBITDA
$2.98 M (USD)-27.16as on Dec 31, 2024
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
96
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of TDSPHARM
TDSPHARM is a publicly listed company on the KRX with ticker symbol 464280 in South Korea, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of TDSPHARM
TDSPHARM offers a comprehensive portfolio of products and services, including General Medicines, Specialized Medicines, and Medical Supplies.
Over-the-counter drugs delivered via transdermal patches.
Prescription drugs using innovative transdermal technology.
Non-drug items like patches for various applications.
Funding Insights of TDSPHARM
Detailed funding history for TDSPHARM
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by TDSPHARM
Investment portfolio details for TDSPHARM
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - TDSPHARM
Detailed financials for TDSPHARM
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Tdspharm Comparisons
Peer comparison for TDSPHARM
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of TDSPHARM
TDSPHARM operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Merck, AbbVie, Lilly, Roche and Novo Nordisk, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Pharmaceutical products are manufactured and marketed worldwide.
|
|
| Locked | Locked | Locked |
Biopharmaceutical research and drug development are conducted globally by AbbVie.
|
|
| Locked | Locked | Locked |
Traditional pharmaceutical medicines are developed for multiple health fields.
|
|
| Locked | Locked | Locked |
Pharmaceuticals and diagnostics kits are developed for various diseases.
|
|
| Locked | Locked | Locked |
Drugs for diabetes, obesity, hemophilia, and hormone therapy are manufactured.
|
|
| Locked | Locked | Locked |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed.
|
Detailed competitors of TDSPHARM
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Tdspharm
Complete news archive for TDSPHARM
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about TDSPHARM
TDSPHARM was founded in 2002.
TDSPHARM is headquartered in Eumseong, South Korea. It is registered at Eumseong, Chungcheongbuk-do, South Korea.
As of Dec 31, 2024, the latest employee count at TDSPHARM is 96.
Annual revenue of TDSPHARM is $18.66M as on Dec 31, 2024.
TDS Pharm Co., Ltd. was established in 2002 within the pharmaceutical sector. Transdermal drug delivery systems are developed and manufactured to facilitate medication delivery through the skin. These systems address conditions including pain management and skin irritations. Operations focus on production processes tailored to industry standards, with products distributed to meet pharmaceutical needs.
TDSPHARM's top competitors include Merck, Roivant Sciences and Amgen.
TDSPHARM offers General Medicines, Specialized Medicines, and Medical Supplies.
Yes, TDSPHARM is publicly traded on KRX under the ticker symbol 464280.
The ticker symbol of TDSPHARM is 464280 on KRX.